ThinkEquity
http://www.thinkequity.comThinkEquity offers research, investment banking, wealth management, and asset management services for institutional and individual investors.
View Older Stories View More Recent Stories
-
iSpecimen Inc. Announces Closing of Approximately $21 Million Private Placement
-
Snow Lake Resources Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriter’s Over-Allotment Option
-
Snow Lake Resources Ltd. (LITM) Prices 3.2M Share IPO at $7.50/sh
-
Snow Lake Resources Ltd. Announces Pricing of Initial Public Offering
-
TG Venture Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing on November 22, 2021
-
Tivic Health Systems, Inc. Announces Closing of Initial Public Offering
-
Tivic Health Systems, Inc. (TIVC) Prices 3M Share IPO at $5/sh
-
Tivic Health Systems, Inc. Announces Pricing of Initial Public Offering
-
TG Venture Acquisition Corp. Announces Closing of $115 Million Initial Public Offering
-
Samsara Vision (SMSA) Files IPO Registration Statement
-
TG Venture Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
TG Venture Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
TRAQIQ, INC (TRIQ) Files IPO Registration Statement
-
Marpai, Inc. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option
-
FG Financial Group, Inc. Announces Closing of Public Offering
-
Marpai (MRAI) IPO Opens Modestly Higher
-
Marpai, Inc. (MRAI) Prices 6.25M Share IPO at $4/sh
-
Marpai, Inc. Announces Pricing of Initial Public Offering
-
FG Financial Group, Inc (FGF) Prices 652K Share Offering at $4/sh
-
FG Financial Group, Inc. Announces Pricing of Public Offering
-
Context Therapeutics® Announces Closing of Initial Public Offering, Including Full Exercise of Underwriter’s Over-allotment Option
-
Context Therapeutics® Announces Closing of Initial Public Offering, Including Full Exercise of Underwriter’s Over-allotment Option
-
Nuvectis Pharma, Inc (NVCT) Files IPO Registration Statement
-
Genius Group (GNS) Files IPO Registration Statement
-
2021 Psychedelic Investor Guide Released
-
Context Therapeutics Inc. (CNTX) Prices 5M Share IPO $5/sh
-
Context Therapeutics® Announces Pricing of Initial Public Offering
-
Context Therapeutics® Announces Pricing of Initial Public Offering
-
Pre-Open Stock Movers 10/12: (RRD) (TARA) (QTRX) Higher; (CVAC) (RLAY) (TREX) Lower (more...)
-
ThinkEquity Starts PetVivo Holdings Inc (PETV) at Buy
-
Harbor Custom Development, Inc. Announces Closing of $36 Million Public Offering of Convertible Preferred Shares & Warrants
-
Harbor Custom Development, Inc. Announces Closing of $36 Million Public Offering of Convertible Preferred Shares & Warrants
-
Nuvectis Pharma (NVCT) Files For Up to $30M IPO
-
Harbor Custom Development, Inc. Announces Pricing of $36 Million Public Offering of Convertible Preferred Shares & Warrants
-
Harbor Custom Development, Inc. Announces Pricing of $36 Million Public Offering of Convertible Preferred Shares & Warrants
-
ThinkEquity Starts Draganfly Inc. (DPRO) at Buy, Earlier Today
-
EzFill Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option
-
EzFill Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option
-
Immix Biopharma (IMMX) Files for Up to 24.75M Share IPO
-
Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock
-
EzFill Holdings (EZFL) IPO Opens 12% Higher
-
Draganfly Announces Exercise of Over-Allotment Option
-
Draganfly Announces Exercise of Over-Allotment Option
-
EzFill Holdings, Inc. (EZFL) Prices 6.25M Share IPO at $4/sh
-
EzFill Announces Pricing of Initial Public Offering
-
EzFill Announces Pricing of Initial Public Offering
-
Virpax Pharmaceuticals (VRPX) Prices 6.67M Share Offering at $6/sh
-
Virpax® Pharmaceuticals Announces Pricing of $40 Million Public Offering of Common Stock
-
ProPhase Labs (PRPH) Announces $6 Million Stock Repurchase Program
-
ProPhase Labs Announces $6 Million Stock Repurchase Program

